Biotech Companies Looking for New Weapons in Battle of the Bulge

Nov 15, 2004 at 05:20 pm by steve

By any standards, Nastech's deal to develop a new obesity drug with Merck was a rich one: $5 million in an upfront payment to co-develop an experimental new treatment; $131 mi.... Read More

Education and Research are the Keys to Advances in Neurology>

Nov 15, 2004 at 05:18 pm by steve

"Neurological disorders have always challenged the best efforts of medicine," says Dr. Audrey Penn, deputy director of NINDS. To her, the nervous system, with it intricate wor.... Read More

Workforce Trends Point to Growing Physician Shortage

Nov 15, 2004 at 05:16 pm by steve

The head of the Association of American Medical College's new Center for Workforce Studies says that a variety of healthcare trends are combining to create a likely shortage o.... Read More

Blue Cross Chief Tries to Set Record Straight On Plan Profitability

Nov 15, 2004 at 04:45 pm by steve

The head of the national BlueCross BlueShield Association has begun to urge health plans to get out in the community and start correcting a growing misperception about the amo.... Read More

Aetna Creates New Specialty Pharma Venture to Manage Drugs for the Chronically Ill

Nov 15, 2004 at 04:42 pm by steve

Intent on finding new tools to help manage the soaring cost of drugs, Aetna has begun setting up a joint venture specialty pharmacy that will concentrate on managing the cost.... Read More